Print Page  Close Window

SEC Filings

VITAE PHARMACEUTICALS, INC filed this Form S-1 on 08/12/2014
Entire Document


(f)                      “Company” shall mean Concurrent Pharmaceuticals, Inc., a Delaware corporation.


(g)                     “Consultant” shall mean a person who performs bona fide services for the Company, a Parent or a Subsidiary as a consultant or advisor, excluding Employees and Outside Directors.


(h)                    “Disability” shall mean that the Optionee is unable to engage in any substantial gainful activity by reason of any medically determinable physical or mental impairment.


(i)                        “Employee” shall mean any individual who is a common-law employee of the Company, a Parent or a Subsidiary.


(j)                       “Exercise Price” shall mean the amount for which one Share may be purchased upon exercise of an Option, as specified by the Board of Directors in the applicable Stock Option Agreement.


(k)                    “Fair Market Value” shall mean the fair market value of a Share, as determined by the Board of Directors in good faith. Such determination shall be conclusive and binding on all persons.


(l)                        “Immediate Family” shall mean any child, stepchild, grandchild, parent, stepparent, grandparent, spouse, sibling, mother-in-law, father-in-law, son-in-law, daughter-in-law, brother-in-law or sister-in-law and shall include adoptive relationships.


(m)                “ISO” shall mean an employee incentive stock option described in Section 422(b) of the Code.


(n)                    “Nonstatutory Option” shall mean a stock option not described in Sections 422(b) or 423(b) of the Code.


(o)                    “Option” shall mean an ISO or Nonstatutory Option granted under the Plan and entitling the holder to purchase Shares.


(p)                    “Optionee” shall mean a person who holds an Option.


(q)                    “Outside Director” shall mean a member of the Board of Directors who is not an Employee.


(r)                       “Parent” shall mean any corporation (other than the Company) in an unbroken chain of corporations ending with the Company, if each of the corporations other than the Company owns stock possessing 50% or more of the total combined voting power of all classes of stock in one of the other corporations in such chain. A corporation that attains the status of a Parent on a date after the adoption of the Plan shall be considered a Parent commencing as of such date.


(s)                      “Plan” shall mean this Concurrent Pharmaceuticals, Inc. 2004 Stock Plan.